Gewirtz R J, Steinberg G K, Crowley R, Levy R P
Department of Neurosurgery, Stanford Stroke Center, Stanford University School of Medicine, California, USA.
Neurosurgery. 1998 Apr;42(4):738-42; discussion 742-3. doi: 10.1097/00006123-199804000-00031.
The goal of this study was to evaluate the pathological changes associated with radiation treatment (stereotactic radiosurgery or conventional irradiation) of angiographically occult vascular malformations (AOVMs).
Eleven patients underwent surgical resection of an AOVM in the mesial temporal lobe, brain stem, thalamus, or basal ganglia after previous radiation treatment. The indications for surgery were recurrent symptomatic bleeding from the lesion in 10 patients and recurrent intractable seizures in 1 patient. Radiation was used as the initial therapy because the risk of surgical resection was deemed too high. Three patients received conventional radiation therapy of 3000 to 5400 rads at an outside institution. One patient received radiosurgery with the gamma knife at another institution using a dose of 15 Gy to the margin. The remaining 7 patients received stereotactic radiosurgery with a helium-ion particle beam. The dose range was from 18 to 26 Gy equivalents. The interval from radiation to surgical resection ranged from 1 to 10 years, with a mean of 3.5 years. These lesions were compared with 10 nonirradiated cavernous malformations.
One irradiated lesion was identified pathologically as a true arteriovenous malformation despite being angiographically occult. This lesion did not demonstrate significant changes in the vasculature but did have radiation necrosis of the surrounding brain 5 years after 25 Gy equivalents of helium-ion radiosurgery. Two other specimens were too small to identify the type of vascular malformation adequately. Of the remaining eight malformations identified as cavernous malformations, six showed a combination of marked fibrosis of the vascular channels, fibrinoid necrosis, and ferrugination. However, the fibrinoid necrosis was the only finding unique to the irradiated lesions compared with nonirradiated controls. All the irradiated lesions still had patent vascular channels; none were completely thrombosed.
Radiosurgery or conventional radiation therapy did not cause histologic vascular obliteration in intracranial AOVMs evaluated 1 to 10 years (mean 3.5 yr) after radiation delivery. It should be recognized that these patients are irradiation failures who may not be representative of all irradiated patients. However, recurrent bleeding from AOVMs may relate to poor radiation response in some patients.
本研究的目的是评估与血管造影隐匿性血管畸形(AOVM)的放射治疗(立体定向放射外科或传统照射)相关的病理变化。
11例患者在先前接受放射治疗后,接受了位于颞叶内侧、脑干、丘脑或基底节的AOVM手术切除。手术指征为10例患者病变反复出现症状性出血,1例患者反复出现难治性癫痫。由于手术切除风险被认为过高,放射治疗被用作初始治疗。3例患者在外部机构接受了3000至5400拉德的传统放射治疗。1例患者在另一机构接受伽玛刀放射外科治疗,边缘剂量为15 Gy。其余7例患者接受氦离子粒子束立体定向放射外科治疗。剂量范围为18至26 Gy当量。从放射治疗到手术切除的间隔时间为1至10年,平均为3.5年。将这些病变与10例未接受照射的海绵状畸形进行比较。
尽管血管造影隐匿,但1个接受照射的病变在病理上被确认为真正的动静脉畸形。该病变血管系统未显示明显变化,但在接受25 Gy当量氦离子放射外科治疗5年后,周围脑组织出现放射性坏死。另外2个标本太小,无法充分确定血管畸形的类型。在其余8个被确认为海绵状畸形的病变中,6个显示血管通道明显纤维化、纤维蛋白样坏死和铁质沉着的组合。然而与未接受照射的对照相比,纤维蛋白样坏死是接受照射病变唯一独特的发现。所有接受照射的病变血管通道仍通畅;无一完全血栓形成。
在放射治疗后1至10年(平均3.5年)评估的颅内AOVM中,放射外科或传统放射治疗未导致组织学上的血管闭塞。应该认识到,这些患者是放射治疗失败的病例,可能不代表所有接受照射的患者。然而,AOVM的反复出血可能与一些患者放射反应不佳有关。